The DOI matches its Crossref record; 315 of the 315 references it cites were found in a registry or an index.
Targeting the Latent Reservoir for HIV-1
Open accessAbstract
&NA; Antiretroviral therapy can effectively block HIV‐1 replication and prevent or reverse immunodeficiency in HIV‐1‐infected individuals. However, viral replication resumes within weeks of treatment interruption. The major barrier to a cure is a small pool of resting memory CD4+ T cells that harbor latent HIV‐1 proviruses. This latent reservoir is now the focus of an intense international research effort. We describe how the reservoir is established, challenges involved in eliminating it, and pharmacologic and immunologic strategies for targeting this reservoir. The development of a successful cure strategy will most likely require understanding the mechanisms that maintain HIV‐1 proviruses in a latent state and pathways that drive the proliferation of infected cells, which slows reservoir decay. In addition, a cure will require the development of effective immunologic approaches to eliminating infected cells. There is renewed optimism about the prospect of a cure, and the interventions discussed here could pave the way. &NA; Developing a cure for HIV‐1 requires understanding the mechanisms of HIV‐1 persistence in the latent reservoir. In this review, we discuss historical and recent paradigms in the HIV‐1 persistence field as well as novel immunologic and pharmacologic strategies for eliminating this reservoir.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. (1995) · Nature · doi:10.1038/373123a0 · Cited by 4,267
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Viral dynamics in human immunodeficiency virus type 1 infection
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) · Nature · doi:10.1038/373117a0 · Cited by 3,260
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
Self-citationVaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma
Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., & Kingsley, L. A. (1996) · Science · doi:10.1126/science.272.5265.1167 · Cited by 2,660
Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes
Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A., Racz, P., Tenner-Racz, K., Dalesandro, M., Scallon, B. J., et al. (1999) · Science · doi:10.1126/science.283.5403.857 · Cited by 2,187
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997) · Science · doi:10.1126/science.278.5341.1291 · Cited by 2,186
Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
Self-citationMolecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Im, S. J., Hashimoto, M., Gerner, M. Y., Lee, J., Kissick, H. T., Burger, M. C., Shan, Q., Hale, J. S., Lee, J., Nasti, T. H., et al. (2016) · Nature · doi:10.1038/nature19330 · Cited by 2,070
Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., et al. (1997) · Nature · doi:10.1038/387183a0 · Cited by 2,050
Self-citationAn inducible transcription factor activates expression of human immunodeficiency virus in T cells
Nabel, G., & Baltimore, D. (1987) · Nature · doi:10.1038/326711a0 · Cited by 2,041
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Chun, T.-W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,977
Tissue-Resident Macrophage Ontogeny and Homeostasis
Ginhoux, F., & Guilliams, M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.024 · Cited by 1,884
Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M., & Oldstone, M. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.6103-6110.1994 · Cited by 1,882
Decay characteristics of HIV-1-infected compartments during combination therapy
Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M., & Ho, D. D. (1997) · Nature · doi:10.1038/387188a0 · Cited by 1,880
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
Hütter, G., Nowak, D., Mossner, M., Ganepola, S., Müßig, A., Allers, K., Schneider, T., Hofmann, J., Kücherer, C., Blau, O., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0802905 · Cited by 1,837
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,832
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
Gartner, S., Markovits, P., Markovitz, D. M., Kaplan, M. H., Gallo, R. C., & Popovic, M. (1986) · Science · doi:10.1126/science.3014648 · Cited by 1,807
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Chomont, N., El-Far, M., Ancuta, P., Trautmann, L., Procopio, F. A., Yassine-Diab, B., Boucher, G., Boulassel, M.-R., Ghattas, G., Brenchley, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1972 · Cited by 1,722
Siliciano, J. D., Kajdas, J., Finzi, D., Quinn, T. C., Chadwick, K., Margolick, J. B., Kovacs, C., Gange, S. J., & Siliciano, R. F. (2003) · Nature Medicine · doi:10.1038/nm880 · Cited by 1,703
Self-citationWei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1896-1905.2002 · Cited by 1,569
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
Larder, B. A., Darby, G., & Richman, D. D. (1989) · Science · doi:10.1126/science.2467383 · Cited by 1,559
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Veazey, R. S., DeMaria, M., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H. L., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,407
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure
Ho, Y.-C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I. S., Lai, J., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · Cell · doi:10.1016/j.cell.2013.09.020 · Cited by 1,405
Self-citationMolecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,354
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,353
HIV preferentially infects HIV-specific CD4+ T cells
Douek, D. C., Brenchley, J. M., Betts, M. R., Ambrozak, D. R., Hill, B. J., Okamoto, Y., Casazza, J. P., Kuruppu, J., Kunstman, K., Wolinsky, S., et al. (2002) · Nature · doi:10.1038/417095a · Cited by 1,262
Wei, P., Garber, M. E., Fang, S.-M., Fischer, W. H., & Jones, K. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80939-3 · Cited by 1,249
High Levels of HIV-1 in Plasma During All Stages of Infection Determined By Competitive PCR
Piatak, M., Saag, M. S., Yang, L. C., Clark, S. J., Kappes, J. C., Luk, K.-C., Hahn, B. H., Shaw, G. M., & Lifson, J. D. (1993) · Science · doi:10.1126/science.8096089 · Cited by 1,237
Borrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183
Controlling the elongation phase of transcription with P-TEFb
Peterlin, B. M., & Price, D. H. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.014 · Cited by 1,144
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
Archin, N. M., Liberty, A. L., Kashuba, A. D., Choudhary, S. K., Kuruc, J. D., Crooks, A. M., Parker, D. C., Anderson, E. M., Kearney, M. F., Strain, M. C., et al. (2012) · Nature · doi:10.1038/nature11286 · Cited by 1,139
The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
Bleul, C. C., Wu, L., Hoxie, J. A., Springer, T. A., & Mackay, C. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1925 · Cited by 1,134
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
Hansen, S. G., Ford, J. C., Lewis, M. S., Ventura, A. B., Hughes, C. M., Coyne-Johnson, L., Whizin, N., Oswald, K., Shoemaker, R., Swanson, T., et al. (2011) · Nature · doi:10.1038/nature10003 · Cited by 988
Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product
Kao, S.-Y., Calman, A. F., Luciw, P. A., & Peterlin, B. M. (1987) · Nature · doi:10.1038/330489a0 · Cited by 909
Human memory T cells: generation, compartmentalization and homeostasis
Farber, D. L., Yudanin, N. A., & Restifo, N. P. (2014) · Nature Reviews Immunology · doi:10.1038/nri3567 · Cited by 897 · cited 2×
“Resting memory CD4+ T cells can undergo homeostatic and antigen-driven proliferation (Farber et al., 2014).”
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection
Petrovas, C., Casazza, J. P., Brenchley, J. M., Price, D. A., Gostick, E., Adams, W. C., Precopio, M. L., Schacker, T., Roederer, M., Douek, D. C., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061496 · Cited by 889
Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889
Cohen, G. B., Gandhi, R. T., Davis, D. M., Mandelboim, O., Chen, B. K., Strominger, J. L., & Baltimore, D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80065-5 · Cited by 861
Fehniger, T. A., Cooper, M. A., Nuovo, G. J., Cella, M., Facchetti, F., Colonna, M., & Caligiuri, M. A. (2003) · Blood · doi:10.1182/blood-2002-09-2876 · Cited by 857
Kamphorst, A. O., Pillai, R. N., Yang, S., Nasti, T. H., Akondy, R. S., Wieland, A., Sica, G. L., Yu, K., Koenig, L., Patel, N. T., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705327114 · Cited by 854
Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
Maldarelli, F., Wu, X., Su, L., Simonetti, F. R., Shao, W., Hill, S., Spindler, J., Ferris, A. L., Mellors, J. W., Kearney, M. F., et al. (2014) · Science · doi:10.1126/science.1254194 · Cited by 849
Davey, R. T., Bhat, N., Yoder, C., Chun, T.-W., Metcalf, J. A., Dewar, R., Natarajan, V., Lempicki, R. A., Adelsberger, J. W., Miller, K. D., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15109 · Cited by 849
Chun, T.-W., Engel, D., Berrey, M. M., Shea, T., Corey, L., & Fauci, A. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8869 · Cited by 846
The Challenge of Finding a Cure for HIV Infection
Richman, D. D., Margolis, D. M., Delaney, M., Greene, W. C., Hazuda, D., & Pomerantz, R. J. (2009) · Science · doi:10.1126/science.1165706 · Cited by 846
HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase
Goldstone, D. C., Ennis-Adeniran, V., Hedden, J. J., Groom, H. C. T., Rice, G. I., Christodoulou, E., Walker, P. A., Kelly, G., Haire, L. F., Yap, M. W., et al. (2011) · Nature · doi:10.1038/nature10623 · Cited by 831
HIV infection: epidemiology, pathogenesis, treatment, and prevention
Maartens, G., Celum, C., & Lewin, S. R. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60164-1 · Cited by 830
Lopez-Vergès, S., Milush, J. M., Schwartz, B. S., Pando, M. J., Jarjoura, J., York, V. A., Houchins, J. P., Miller, S., Kang, S.-M., Norris, P. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110900108 · Cited by 822
Direct observation of ligand recognition by T cells
Irvine, D. J., Purbhoo, M. A., Krogsgaard, M., & Davis, M. M. (2002) · Nature · doi:10.1038/nature01076 · Cited by 820
CREB-binding protein/p300 are transcriptional coactivators of p65
Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., & Collins, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2927 · Cited by 816
In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
Chun, T.-W., Finzi, D., Margolick, J., Chadwick, K., Schwartz, D., & Siliciano, R. F. (1995) · Nature Medicine · doi:10.1038/nm1295-1284 · Cited by 787
Self-citationHIV-specific cytotoxic T lymphocytes in seropositive individuals
Walker, B. D., Chakrabarti, S., Moss, B., Paradis, T. J., Flynn, T., Durno, A. G., Blumberg, R. S., Kaplan, J. C., Hirsch, M. S., & Schooley, R. T. (1987) · Nature · doi:10.1038/328345a0 · Cited by 784
Duh, E. J., Maury, W. J., Folks, T. M., Fauci, A. S., & Rabson, A. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5974 · Cited by 767
Jones, R. B., Ndhlovu, L. C., Barbour, J. D., Sheth, P. M., Jha, A. R., Long, B. R., Wong, J. C., Satkunarajah, M., Schweneker, M., Chapman, J. M., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081398 · Cited by 753
Pitcher, C. J., Quittner, C., Peterson, D. M., Connors, M., Koup, R. A., Maino, V. C., & Picker, L. J. (1999) · Nature Medicine · doi:10.1038/8400 · Cited by 746
Takaki, A., Wiese, M., Maertens, G., Depla, E., Seifert, U., Liebetrau, A., Miller, J. L., Manns, M. P., & Rehermann, B. (2000) · Nature Medicine · doi:10.1038/75063 · Cited by 739
Defective proviruses rapidly accumulate during acute HIV-1 infection
Bruner, K. M., Murray, A. J., Pollack, R. A., Soliman, M. G., Laskey, S. B., Capoferri, A. A., Lai, J., Strain, M. C., Lada, S. M., Hoh, R., et al. (2016) · Nature Medicine · doi:10.1038/nm.4156 · Cited by 737
Self-citationShan, L., Deng, K., Shroff, N. S., Durand, C. M., Rabi, S. A., Yang, H.-C., Zhang, H., Margolick, J. B., Blankson, J. N., & Siliciano, R. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.014 · Cited by 714
Self-citationTranscription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro
Zhu, Y., Pe’ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M. B., & Price, D. H. (1997) · Genes & Development · doi:10.1101/gad.11.20.2622 · Cited by 696
Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
Price, D. A., Goulder, P. J. R., Klenerman, P., Sewell, A. K., Easterbrook, P. J., Troop, M., Bangham, C. R. M., & Phillips, R. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1890 · Cited by 688
Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
Wagner, T. A., McLaughlin, S., Garg, K., Cheung, C. Y. K., Larsen, B. B., Styrchak, S., Huang, H. C., Edlefsen, P. T., Mullins, J. I., & Frenkel, L. M. (2014) · Science · doi:10.1126/science.1256304 · Cited by 677
Hansen, S. G., Vieville, C., Whizin, N., Coyne-Johnson, L., Siess, D. C., Drummond, D. D., Legasse, A. W., Axthelm, M. K., Oswald, K., Trubey, C. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1935 · Cited by 675
A role for LEDGF/p75 in targeting HIV DNA integration
Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R., & Bushman, F. (2005) · Nature Medicine · doi:10.1038/nm1329 · Cited by 658
CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions
Hashimoto, M., Kamphorst, A. O., Im, S. J., Kissick, H. T., Pillai, R. N., Ramalingam, S. S., Araki, K., & Ahmed, R. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-012017-043208 · Cited by 656
Barouch, D. H., Whitney, J. B., Moldt, B., Klein, F., Oliveira, T. Y., Liu, J., Stephenson, K. E., Chang, H.-W., Shekhar, K., Gupta, S., et al. (2013) · Nature · doi:10.1038/nature12744 · Cited by 644
Goonetilleke, N., Liu, M. K. P., Salazar-Gonzalez, J. F., Ferrari, G., Giorgi, E., Ganusov, V. V., Keele, B. F., Learn, G. H., Turnbull, E. L., Salazar, M. G., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090365 · Cited by 641
Perreau, M., Savoye, A.-L., De Crignis, E., Corpataux, J.-M., Cubas, R., Haddad, E. K., De Leval, L., Graziosi, C., & Pantaleo, G. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121932 · Cited by 630
Weinberger, L. S., Burnett, J. C., Toettcher, J. E., Arkin, A. P., & Schaffer, D. V. (2005) · Cell · doi:10.1016/j.cell.2005.06.006 · Cited by 630
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys
Whitney, J. B., Hill, A. L., Sanisetty, S., Penaloza-MacMaster, P., Liu, J., Shetty, M., Parenteau, L., Cabral, C., Shields, J., Blackmore, S., et al. (2014) · Nature · doi:10.1038/nature13594 · Cited by 629
Rasmussen, T. A., Tolstrup, M., Brinkmann, C. R., Olesen, R., Erikstrup, C., Solomon, A., Winckelmann, A., Palmer, S., Dinarello, C., Buzon, M., et al. (2014) · The Lancet HIV · doi:10.1016/s2352-3018(14)70014-1 · Cited by 628
Persistent HIV-1 replication maintains the tissue reservoir during therapy
Lorenzo-Redondo, R., Fryer, H. R., Bedford, T., Kim, E.-Y., Archer, J., Kosakovsky Pond, S. L., Chung, Y.-S., Penugonda, S., Chipman, J. G., Fletcher, C. V., et al. (2016) · Nature · doi:10.1038/nature16933 · Cited by 627
Immune clearance of highly pathogenic SIV infection
Hansen, S. G., Jr, M. P., Ventura, A. B., Hughes, C. M., Gilbride, R. M., Ford, J. C., Oswald, K., Shoemaker, R., Li, Y., Lewis, M. S., et al. (2013) · Nature · doi:10.1038/nature12519 · Cited by 597
SAMHD1 restricts HIV-1 infection in resting CD4+ T cells
Baldauf, H.-M., Pan, X., Erikson, E., Schmidt, S., Daddacha, W., Burggraf, M., Schenkova, K., Ambiel, I., Wabnitz, G., Gramberg, T., et al. (2012) · Nature Medicine · doi:10.1038/nm.2964 · Cited by 597
Ferlazzo, G., Thomas, D., Lin, S.-L., Goodman, K., Morandi, B., Muller, W. A., Moretta, A., & Münz, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1455 · Cited by 589
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
Burton, D. R., & Hangartner, L. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055515 · Cited by 583
Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
Persaud, D., Gay, H., Ziemniak, C., Chen, Y. H., Piatak, M., Chun, T.-W., Strain, M., Richman, D., & Luzuriaga, K. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302976 · Cited by 581
Van Lint, C., Emiliani, S., Ott, M., & Verdin, E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00449.x · Cited by 580
Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade
Blackburn, S. D., Shin, H., Freeman, G. J., & Wherry, E. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801497105 · Cited by 579
Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy
Chun, T., Nickle, D. C., Justement, J. S., Meyers, J. H., Roby, G., Hallahan, C. W., Kottilil, S., Moir, S., Mican, J. M., Mullins, J. I., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527324 · Cited by 574
HIV-1 tat trans-activation requires the loop sequence within tar
Feng, S., & Holland, E. C. (1988) · Nature · doi:10.1038/334165a0 · Cited by 549
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
Mancebo, H. S. Y., Lee, G., Flygare, J., Tomassini, J., Luu, P., Zhu, Y., Peng, J., Blau, C., Hazuda, D., Price, D., et al. (1997) · Genes & Development · doi:10.1101/gad.11.20.2633 · Cited by 544
Sather, D. N., Armann, J., Ching, L. K., Mavrantoni, A., Sellhorn, G., Caldwell, Z., Yu, X., Wood, B., Self, S., Kalams, S., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02036-08 · Cited by 528
Iwai, Y. (2004) · International Immunology · doi:10.1093/intimm/dxh194 · Cited by 527
Identification of multiple cyclin subunits of human P-TEFb
Peng, J., Zhu, Y., Milton, J. T., & Price, D. H. (1998) · Genes & Development · doi:10.1101/gad.12.5.755 · Cited by 519
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Søgaard, O. S., Graversen, M. E., Leth, S., Olesen, R., Brinkmann, C. R., Nissen, S. K., Kjaer, A. S., Schleimann, M. H., Denton, P. W., Hey-Cunningham, W. J., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005142 · Cited by 516
Siliciano, R. F., & Greene, W. C. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007096 · Cited by 513
Self-citationVerdin, E., Paras, P., & Van Lint, C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05994.x · Cited by 510
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
Lehrman, G., Hogue, I. B., Palmer, S., Jennings, C., Spina, C. A., Wiegand, A., Landay, A. L., Coombs, R. W., Richman, D. D., Mellors, J. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67098-5 · Cited by 510
Elliott, J. H., Wightman, F., Solomon, A., Ghneim, K., Ahlers, J., Cameron, M. J., Smith, M. Z., Spelman, T., McMahon, J., Velayudham, P., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004473 · Cited by 504
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
Deng, K., Pertea, M., Rongvaux, A., Wang, L., Durand, C. M., Ghiaur, G., Lai, J., McHugh, H. L., Hao, H., Zhang, H., et al. (2015) · Nature · doi:10.1038/nature14053 · Cited by 504
Self-citationBroadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Bournazos, S., Klein, F., Pietzsch, J., Seaman, M. S., Nussenzweig, M. C., & Ravetch, J. V. (2014) · Cell · doi:10.1016/j.cell.2014.08.023 · Cited by 493
Sodroski, J., Rosen, C., Wong-Staal, F., Salahuddin, S. Z., Popovic, M., Arya, S., Gallo, R. C., & Haseltine, W. A. (1985) · Science · doi:10.1126/science.2981427 · Cited by 493
Bullen, C. K., Laird, G. M., Durand, C. M., Siliciano, J. D., & Siliciano, R. F. (2014) · Nature Medicine · doi:10.1038/nm.3489 · Cited by 488
Self-citationFukazawa, Y., Lum, R., Okoye, A. A., Park, H., Matsuda, K., Bae, J. Y., Hagen, S. I., Shoemaker, R., Deleage, C., Lucero, C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3781 · Cited by 477
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
Scheid, J. F., Horwitz, J. A., Bar-On, Y., Kreider, E. F., Lu, C.-L., Lorenzi, J. C. C., Feldmann, A., Braunschweig, M., Nogueira, L., Oliveira, T., et al. (2016) · Nature · doi:10.1038/nature18929 · Cited by 472
Banga, R., Procopio, F. A., Noto, A., Pollakis, G., Cavassini, M., Ohmiti, K., Corpataux, J.-M., de Leval, L., Pantaleo, G., & Perreau, M. (2016) · Nature Medicine · doi:10.1038/nm.4113 · Cited by 471
Jordan, A., Defechereux, P., & Verdin, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1726 · Cited by 467
Lynch, R. M., Boritz, E., Coates, E. E., DeZure, A., Madden, P., Costner, P., Enama, M. E., Plummer, S., Holman, L., Hendel, C. S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad5752 · Cited by 465
Dornadula, G. (1999) · JAMA · doi:10.1001/jama.282.17.1627 · Cited by 463
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
Bar, K. J., Sneller, M. C., Harrison, L. J., Justement, J. S., Overton, E. T., Petrone, M. E., Salantes, D. B., Seamon, C. A., Scheinfeld, B., Kwan, R. W., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1608243 · Cited by 455
Activation of the HIV-1 LTR by T Cell Mitogens and the Trans-Activator Protein of HTLV-I
Siekevitz, M., Josephs, S. F., Dukovich, M., Peffer, N., Wong-Staal, F., & Greene, W. C. (1987) · Science · doi:10.1126/science.2825351 · Cited by 452
Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue
Doitsh, G., Cavrois, M., Lassen, K. G., Zepeda, O., Yang, Z., Santiago, M. L., Hebbeler, A. M., & Greene, W. C. (2010) · Cell · doi:10.1016/j.cell.2010.11.001 · Cited by 452
HIV-1 Integration Landscape during Latent and Active Infection
Cohn, L. B., Silva, I. T., Oliveira, T. Y., Rosales, R. A., Parrish, E. H., Learn, G. H., Hahn, B. H., Czartoski, J. L., McElrath, M. J., Lehmann, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.020 · Cited by 444
Self-citationDinoso, J. B., Kim, S. Y., Wiegand, A. M., Palmer, S. E., Gange, S. J., Cranmer, L., O'Shea, A., Callender, M., Spivak, A., Brennan, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903107106 · Cited by 441
Self-citationCytomegalovirus Vectors Violate CD8 + T Cell Epitope Recognition Paradigms
Hansen, S. G., Sacha, J. B., Hughes, C. M., Ford, J. C., Burwitz, B. J., Scholz, I., Gilbride, R. M., Lewis, M. S., Gilliam, A. N., Ventura, A. B., et al. (2013) · Science · doi:10.1126/science.1237874 · Cited by 432
NF‐κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation
Williams, S. A., Chen, L., Kwon, H., Ruiz‐Jarabo, C. M., Verdin, E., & Greene, W. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600900 · Cited by 430
Re-emergence of HIV after stopping therapy
Chun, T.-W., Davey, R. T., Engel, D., Lane, H. C., & Fauci, A. S. (1999) · Nature · doi:10.1038/44755 · Cited by 428
CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART
Fromentin, R., Bakeman, W., Lawani, M. B., Khoury, G., Hartogensis, W., DaFonseca, S., Killian, M., Epling, L., Hoh, R., Sinclair, E., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005761 · Cited by 422
Expansion of HIV-specific T follicular helper cells in chronic HIV infection
Lindqvist, M., van Lunzen, J., Soghoian, D. Z., Kuhl, B. D., Ranasinghe, S., Kranias, G., Flanders, M. D., Cutler, S., Yudanin, N., Muller, M. I., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64314 · Cited by 418
Bailey, J. R., Sedaghat, A. R., Kieffer, T., Brennan, T., Lee, P. K., Wind-Rotolo, M., Haggerty, C. M., Kamireddi, A. R., Liu, Y., Lee, J., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00591-06 · Cited by 417
Self-citationGetting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV
Kim, Y., Anderson, J. L., & Lewin, S. R. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2017.12.004 · Cited by 414
Lambotte, O., Boufassa, F., Madec, Y., Nguyen, A., Goujard, C., Meyer, L., Rouzioux, C., Venet, A., Delfraissy, J.-F., & SEROCO-HEMOCO Study Group (2005) · Clinical Infectious Diseases · doi:10.1086/433188 · Cited by 409
Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies
Crooks, A. M., Bateson, R., Cope, A. B., Dahl, N. P., Griggs, M. K., Kuruc, J. D., Gay, C. L., Eron, J. J., Margolis, D. M., Bosch, R. J., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv218 · Cited by 406
Henrich, T. J., Hanhauser, E., Marty, F. M., Sirignano, M. N., Keating, S., Lee, T.-H., Robles, Y. P., Davis, B. T., Li, J. Z., Heisey, A., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-1027 · Cited by 401
Böhnlein, E., Lowenthal, J. W., Siekevitz, M., Ballard, D. W., Franza, B. R., & Greene, W. C. (1988) · Cell · doi:10.1016/0092-8674(88)90099-2 · Cited by 400
Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAART
Nettles, R. E. (2005) · JAMA · doi:10.1001/jama.293.7.817 · Cited by 395
Ex vivo analysis identifies effective HIV-1 latency–reversing drug combinations
Laird, G. M., Bullen, C. K., Rosenbloom, D. I. S., Martin, A. R., Hill, A. L., Durand, C. M., Siliciano, J. D., & Siliciano, R. F. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80142 · Cited by 391
Self-citationHalper-Stromberg, A., Lu, C.-L., Klein, F., Horwitz, J. A., Bournazos, S., Nogueira, L., Eisenreich, T. R., Liu, C., Gazumyan, A., Schaefer, U., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.043 · Cited by 381
Hosmane, N. N., Kwon, K. J., Bruner, K. M., Capoferri, A. A., Beg, S., Rosenbloom, D. I. S., Keele, B. F., Ho, Y.-C., Siliciano, J. D., & Siliciano, R. F. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20170193 · Cited by 381
Self-citationEpigenetic Regulation of HIV-1 Latency by Cytosine Methylation
Kauder, S. E., Bosque, A., Lindqvist, A., Planelles, V., & Verdin, E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000495 · Cited by 374
Clonally expanded CD4 + T cells can produce infectious HIV-1 in vivo
Simonetti, F. R., Sobolewski, M. D., Fyne, E., Shao, W., Spindler, J., Hattori, J., Anderson, E. M., Watters, S. A., Hill, S., Wu, X., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522675113 · Cited by 372
Fujinaga, K., Irwin, D., Huang, Y., Taube, R., Kurosu, T., & Peterlin, B. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.787-795.2004 · Cited by 371
Pollack, R. A., Jones, R. B., Pertea, M., Bruner, K. M., Martin, A. R., Thomas, A. S., Capoferri, A. A., Beg, S. A., Huang, S.-H., Karandish, S., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.03.008 · Cited by 370
Self-citationHiener, B., Horsburgh, B. A., Eden, J.-S., Barton, K., Schlub, T. E., Lee, E., von Stockenstrom, S., Odevall, L., Milush, J. M., Liegler, T., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.081 · Cited by 370
Kalams, S. A., Buchbinder, S. P., Rosenberg, E. S., Billingsley, J. M., Colbert, D. S., Jones, N. G., Shea, A. K., Trocha, A. K., & Walker, B. D. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6715-6720.1999 · Cited by 369
HIV-1 adaptation to NK-cell-mediated immune pressure
Alter, G., Heckerman, D., Schneidewind, A., Fadda, L., Kadie, C. M., Carlson, J. M., Oniangue-Ndza, C., Martin, M., Li, B., Khakoo, S. I., et al. (2011) · Nature · doi:10.1038/nature10237 · Cited by 347
Enhanced clearance of HIV-1–infected cells by broadly neutralizing antibodies against HIV-1 in vivo
Lu, C.-L., Murakowski, D. K., Bournazos, S., Schoofs, T., Sarkar, D., Halper-Stromberg, A., Horwitz, J. A., Nogueira, L., Golijanin, J., Gazumyan, A., et al. (2016) · Science · doi:10.1126/science.aaf1279 · Cited by 347
Coull, J. J., Romerio, F., Sun, J.-M., Volker, J. L., Galvin, K. M., Davie, J. R., Shi, Y., Hansen, U., & Margolis, D. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.6790-6799.2000 · Cited by 346
Imamichi, H., Dewar, R. L., Adelsberger, J. W., Rehm, C. A., O’Doherty, U., Paxinos, E. E., Fauci, A. S., & Lane, H. C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609057113 · Cited by 344
HIV-1 transcription and latency: an update
Van Lint, C., Bouchat, S., & Marcello, A. (2013) · Retrovirology · doi:10.1186/1742-4690-10-67 · Cited by 338
ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia
Maldarelli, F., Palmer, S., King, M. S., Wiegand, A., Polis, M. A., Mican, J., Kovacs, J. A., Davey, R. T., Rock-Kress, D., Dewar, R., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030046 · Cited by 333
Han, Y., Lassen, K., Monie, D., Sedaghat, A. R., Shimoji, S., Liu, X., Pierson, T. C., Margolick, J. B., Siliciano, R. F., & Siliciano, J. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6122-6133.2004 · Cited by 327
Self-citationT cell exhaustion during persistent viral infections
Kahan, S. M., Wherry, E. J., & Zajac, A. J. (2015) · Virology · doi:10.1016/j.virol.2014.12.033 · Cited by 324
CD4 T follicular helper cell dynamics during SIV infection
Petrovas, C., Yamamoto, T., Gerner, M. Y., Boswell, K. L., Wloka, K., Smith, E. C., Ambrozak, D. R., Sandler, N. G., Timmer, K. J., Sun, X., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63039 · Cited by 317
Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
Mikell, I., Sather, D. N., Kalams, S. A., Altfeld, M., Alter, G., & Stamatatos, L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001251 · Cited by 315
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
Schoofs, T., Klein, F., Braunschweig, M., Kreider, E. F., Feldmann, A., Nogueira, L., Oliveira, T., Lorenzi, J. C. C., Parrish, E. H., Learn, G. H., et al. (2016) · Science · doi:10.1126/science.aaf0972 · Cited by 313
Immunotoxins for targeted cancer therapy
Kreitman, R. J. (2006) · The AAPS Journal · doi:10.1208/aapsj080363 · Cited by 307
Gandhi, R. T., Zheng, L., Bosch, R. J., Chan, E. S., Margolis, D. M., Read, S., Kallungal, B., Palmer, S., Medvik, K., Lederman, M. M., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000321 · Cited by 304
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
Kwong, P. D., & Mascola, J. R. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.029 · Cited by 304
Slingluff, C. L. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e318233e5b2 · Cited by 299
Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells
Lee, G. Q., Orlova-Fink, N., Einkauf, K., Chowdhury, F. Z., Sun, X., Harrington, S., Kuo, H.-H., Hua, S., Chen, H.-R., Ouyang, Z., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93289 · Cited by 292
Broadly targeted CD8 + T cell responses restricted by major histocompatibility complex E
Hansen, S. G., Wu, H. L., Burwitz, B. J., Hughes, C. M., Hammond, K. B., Ventura, A. B., Reed, J. S., Gilbride, R. M., Ainslie, E., Morrow, D. W., et al. (2016) · Science · doi:10.1126/science.aac9475 · Cited by 290
Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs
Coiras, M., López-Huertas, M. R., Pérez-Olmeda, M., & Alcamí, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2223 · Cited by 288
Modulation of Heterochromatin Protein 1 Dynamics in Primary Mammalian Cells
Festenstein, R., Pagakis, S. N., Hiragami, K., Lyon, D., Verreault, A., Sekkali, B., & Kioussis, D. (2003) · Science · doi:10.1126/science.1078694 · Cited by 288
Blankson, J. N., Bailey, J. R., Thayil, S., Yang, H.-C., Lassen, K., Lai, J., Gandhi, S. K., Siliciano, J. D., Williams, T. M., & Siliciano, R. F. (2007) · Journal of Virology · doi:10.1128/jvi.02165-06 · Cited by 283
Self-citationDarcis, G., Kula, A., Bouchat, S., Fujinaga, K., Corazza, F., Ait-Ammar, A., Delacourt, N., Melard, A., Kabeya, K., Vanhulle, C., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005063 · Cited by 281
HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy
Honeycutt, J. B., Thayer, W. O., Baker, C. E., Ribeiro, R. M., Lada, S. M., Cao, Y., Cleary, R. A., Hudgens, M. G., Richman, D. D., & Garcia, J. V. (2017) · Nature Medicine · doi:10.1038/nm.4319 · Cited by 281
Antigen-specific NK cell memory in rhesus macaques
Reeves, R. K., Li, H., Jost, S., Blass, E., Li, H., Schafer, J. L., Varner, V., Manickam, C., Eslamizar, L., Altfeld, M., et al. (2015) · Nature Immunology · doi:10.1038/ni.3227 · Cited by 278
Josefsson, L., von Stockenstrom, S., Faria, N. R., Sinclair, E., Bacchetti, P., Killian, M., Epling, L., Tan, A., Ho, T., Lemey, P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308313110 · Cited by 277
Rothenberger, M. K., Keele, B. F., Wietgrefe, S. W., Fletcher, C. V., Beilman, G. J., Chipman, J. G., Khoruts, A., Estes, J. D., Anderson, J., Callisto, S. P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414926112 · Cited by 277
Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys
Borducchi, E. N., Cabral, C., Stephenson, K. E., Liu, J., Abbink, P., Ng’ang’a, D., Nkolola, J. P., Brinkman, A. L., Peter, L., Lee, B. C., et al. (2016) · Nature · doi:10.1038/nature20583 · Cited by 276
Eradicating HIV-1 infection: seeking to clear a persistent pathogen
Archin, N. M., Sung, J. M., Garrido, C., Soriano-Sarabia, N., & Margolis, D. M. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3352 · Cited by 275
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques
Xu, L., Pegu, A., Rao, E., Doria-Rose, N., Beninga, J., McKee, K., Lord, D. M., Wei, R. R., Deng, G., Louder, M., et al. (2017) · Science · doi:10.1126/science.aan8630 · Cited by 270
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
Hill, A. L., Rosenbloom, D. I. S., Fu, F., Nowak, M. A., & Siliciano, R. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406663111 · Cited by 265
Self-citationViremic Relapse after HIV-1 Remission in a Perinatally Infected Child
Luzuriaga, K., Gay, H., Ziemniak, C., Sanborn, K. B., Somasundaran, M., Rainwater-Lovett, K., Mellors, J. W., Rosenbloom, D., & Persaud, D. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1413931 · Cited by 262
Parada, C. A., & Roeder, R. G. (1996) · Nature · doi:10.1038/384375a0 · Cited by 261
Yang, H.-C., Xing, S., Shan, L., O’Connell, K., Dinoso, J., Shen, A., Zhou, Y., Shrum, C. K., Han, Y., Liu, J. O., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39199 · Cited by 258
Self-citationMolitor, J. A., Walker, W. H., Doerre, S., Ballard, D. W., & Greene, W. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.10028 · Cited by 257
Strain, M. C., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Smith, D. M., Leigh-Brown, A. J., Macaranas, T. R., Lam, R. Y., Daly, O. A., Fischer, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0736332100 · Cited by 254
Transcriptional Interference Antagonizes Proviral Gene Expression to Promote HIV Latency
Lenasi, T., Contreras, X., & Peterlin, B. M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.016 · Cited by 245
Streeck, H., Brumme, Z. L., Anastario, M., Cohen, K. W., Jolin, J. S., Meier, A., Brumme, C. J., Rosenberg, E. S., Alter, G., Allen, T. M., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050100 · Cited by 243
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses
Descours, B., Petitjean, G., López-Zaragoza, J.-L., Bruel, T., Raffel, R., Psomas, C., Reynes, J., Lacabaratz, C., Levy, Y., Schwartz, O., et al. (2017) · Nature · doi:10.1038/nature21710 · Cited by 242
Bui, J. K., Sobolewski, M. D., Keele, B. F., Spindler, J., Musick, A., Wiegand, A., Luke, B. T., Shao, W., Hughes, S. H., Coffin, J. M., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006283 · Cited by 241
Gaudinski, M. R., Coates, E. E., Houser, K. V., Chen, G. L., Yamshchikov, G., Saunders, J. G., Holman, L. A., Gordon, I., Plummer, S., Hendel, C. S., et al. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002493 · Cited by 241
Prins, J. M., Jurriaans, S., van Praag, R. M. E., Blaak, H., van Rij, R., Schellekens, P. T. A., ten Berge, I. J. M., Yong, S.-L., Fox, C. H., Roos, M. T. L., et al. (1999) · AIDS · doi:10.1097/00002030-199912030-00012 · Cited by 237
Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral Therapy
Kearney, M. F., Spindler, J., Shao, W., Yu, S., Anderson, E. M., O'Shea, A., Rehm, C., Poethke, C., Kovacs, N., Mellors, J. W., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004010 · Cited by 235
Cillo, A. R., Sobolewski, M. D., Bosch, R. J., Fyne, E., Piatak, M., Coffin, J. M., & Mellors, J. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402873111 · Cited by 232
Post-treatment control of HIV infection
Conway, J. M., & Perelson, A. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419162112 · Cited by 230
Cutting Edge: Allele-Specific and Peptide-Dependent Interactions between KIR3DL1 and HLA-A and HLA-B
Thananchai, H., Gillespie, G., Martin, M. P., Bashirova, A., Yawata, N., Yawata, M., Easterbrook, P., McVicar, D. W., Maenaka, K., Parham, P., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.33 · Cited by 228
Host Control of HIV-1 Parasitism in T Cells by the Nuclear Factor of Activated T Cells
Kinoshita, S., Chen, B. K., Kaneshima, H., & Nolan, G. P. (1998) · Cell · doi:10.1016/s0092-8674(00)81630-x · Cited by 227
Saleh, S., Solomon, A., Wightman, F., Xhilaga, M., Cameron, P. U., & Lewin, S. R. (2007) · Blood · doi:10.1182/blood-2007-06-097907 · Cited by 227
Gay, C. L., Bosch, R. J., Ritz, J., Hataye, J. M., Aga, E., Tressler, R. L., Mason, S. W., Hwang, C. K., Grasela, D. M., Ray, N., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix191 · Cited by 224
Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane
Wang, Z., Gurule, E. E., Brennan, T. P., Gerold, J. M., Kwon, K. J., Hosmane, N. N., Kumar, M. R., Beg, S. A., Capoferri, A. A., Ray, S. C., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720665115 · Cited by 224
Self-citationCTL Fail to Accumulate at Sites of HIV-1 Replication in Lymphoid Tissue
Connick, E., Mattila, T., Folkvord, J. M., Schlichtemeier, R., Meditz, A. L., Ray, M. G., McCarter, M. D., MaWhinney, S., Hage, A., White, C., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6975 · Cited by 223
McMahon, D., Jones, J., Wiegand, A., Gange, S. J., Kearney, M., Palmer, S., McNulty, S., Metcalf, J. A., Acosta, E., Rehm, C., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/650749 · Cited by 223
Churchill, M. J., Gorry, P. R., Cowley, D., Lal, L., Sonza, S., Purcell, D. F., Thompson, K. A., Gabuzda, D., McArthur, J. C., Pardo, C. A., et al. (2006) · Journal of Neurovirology · doi:10.1080/13550280600748946 · Cited by 221
Tobin, N. H., Learn, G. H., Holte, S. E., Wang, Y., Melvin, A. J., McKernan, J. L., Pawluk, D. M., Mohan, K. M., Lewis, P. F., Mullins, J. I., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9625-9634.2005 · Cited by 217
Nuclear Retention of Multiply Spliced HIV-1 RNA in Resting CD4+ T Cells
Lassen, K. G., Ramyar, K. X., Bailey, J. R., Zhou, Y., & Siliciano, R. F. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020068 · Cited by 216
Self-citationUnderstanding HIV Latency: The Road to an HIV Cure
Dahabieh, M. S., Battivelli, E., & Verdin, E. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-092112-152941 · Cited by 216
Han, Y., Lin, Y. B., An, W., Xu, J., Yang, H.-C., O'Connell, K., Dordai, D., Boeke, J. D., Siliciano, J. D., & Siliciano, R. F. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.06.008 · Cited by 215
Self-citationBrain Cell Reservoirs of Latent Virus in Presymptomatic HIV-Infected Individuals
Thompson, K. A., Cherry, C. L., Bell, J. E., & McLean, C. A. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.039 · Cited by 210
Screening for noise in gene expression identifies drug synergies
Dar, R. D., Hosmane, N. N., Arkin, M. R., Siliciano, R. F., & Weinberger, L. S. (2014) · Science · doi:10.1126/science.1250220 · Cited by 208
Self-citationExperimental approaches to the study of HIV-1 latency
Han, Y., Wind-Rotolo, M., Yang, H.-C., Siliciano, J. D., & Siliciano, R. F. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1580 · Cited by 208
Self-citationJones, R. B., O'Connor, R., Mueller, S., Foley, M., Szeto, G. L., Karel, D., Lichterfeld, M., Kovacs, C., Ostrowski, M. A., Trocha, A., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004287 · Cited by 206
Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy
Gutiérrez, C., Serrano-Villar, S., Madrid-Elena, N., Pérez-Elías, M. J., Martín, M. E., Barbas, C., Ruipérez, J., Muñoz, E., Muñoz-Fernández, M. A., Castor, T., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001064 · Cited by 203
Kieffer, T. L., Finucane, M. M., Nettles, R. E., Quinn, T. C., Broman, K. W., Ray, S. C., Persaud, D., & Siliciano, R. F. (2004) · The Journal of Infectious Diseases · doi:10.1086/382488 · Cited by 201
Self-citationActivation of the ATR-mediated DNA Damage Response by the HIV-1 Viral Protein R
Roshal, M., Kim, B., Zhu, Y., Nghiem, P., & Planelles, V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303948200 · Cited by 200
Sustained virologic control in SIV + macaques after antiretroviral and α 4 β 7 antibody therapy
Byrareddy, S. N., Arthos, J., Cicala, C., Villinger, F., Ortiz, K. T., Little, D., Sidell, N., Kane, M. A., Yu, J., Jones, J. W., et al. (2016) · Science · doi:10.1126/science.aag1276 · Cited by 200
Cited by
Microglial Cells: The Main HIV-1 Reservoir in the Brain
Wallet, C., De Rovere, M., Van Assche, J., Daouad, F., De Wit, S., Gautier, V., Mallon, P. W. G., Marcello, A., Van Lint, C., Rohr, O., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00362 · Cited by 368
HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy
Ganor, Y., Real, F., Sennepin, A., Dutertre, C.-A., Prevedel, L., Xu, L., Tudor, D., Charmeteau, B., Couedel-Courteille, A., Marion, S., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0335-z · Cited by 303
HIV persists throughout deep tissues with repopulation from multiple anatomical sources
Chaillon, A., Gianella, S., Dellicour, S., Rawlings, S. A., Schlub, T. E., De Oliveira, M. F., Ignacio, C., Porrachia, M., Vrancken, B., & Smith, D. M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134815 · Cited by 250
Ait-Ammar, A., Kula, A., Darcis, G., Verdikt, R., De Wit, S., Gautier, V., Mallon, P. W. G., Marcello, A., Rohr, O., & Van Lint, C. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03060 · Cited by 163
Lu, C.-L., Pai, J. A., Nogueira, L., Mendoza, P., Gruell, H., Oliveira, T. Y., Barton, J., Lorenzi, J. C. C., Cohen, Y. Z., Cohn, L. B., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1813512115 · Cited by 77
Metadata
- Authors
- Sengupta, S., & Siliciano, R. F.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 48
- Issue
- 5
- Pages
- 872-895
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2804663340
- Cited by
- 340
- References
- 315
- FWCI
- 21.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.